Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus.
Narshi
Chetan B
CB
Haider
Seema
S
Ford
Charlotte M
CM
Isenberg
David A
DA
Giles
Ian P
IP
D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003520:Cyclophosphamide